Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769234 · ClinicalTrials.gov registry record
EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
A clinical trial, sponsored by Neuronetrix.
- Completed
- Registry status
- 75
- Enrollment target
NCT02769234: Completed study, sponsored by Neuronetrix.
NCT02769234 is a clinical trial that has completed, run by Neuronetrix. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769234 has completed, sponsored by Neuronetrix.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
In a previous study, NCT00582127, two age-matched cohorts, one clinically diagnosed with mild Alzheimer's disease and the other healthy controls, were tested with a hand-held EEG/ERP system to determine if the cohorts could be discriminated using the EEG/ERP measures. This study proposes to retest the AD cohort 18-60 months after their first test to characterize the change in EEG/ERP measures correlated with the longitudinal change in neuropsychological testing.
Interventions
- PROCEDURE ERP/EEG test
- PROCEDURE Psychometric testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-07 |
What the finished NCT02769234 record still lists
NCT02769234 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which ERP/EEG test is the first listed.
NCT02769234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769234 about?
NCT02769234 is a clinical study titled "EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)". In a previous study, NCT00582127, two age-matched cohorts, one clinically diagnosed with mild Alzheimer's disease and the other healthy controls, were tested with a hand-held EEG/ERP system to determine if the cohorts could be discriminated using the EEG/ERP measures. This study proposes to retest t...
What is the current status of trial NCT02769234?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02769234?
The interventions under investigation include: ERP/EEG test (PROCEDURE), Psychometric testing (PROCEDURE).
Who is sponsoring clinical trial NCT02769234?
This trial is sponsored by Neuronetrix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia